Schorn Michelle A, Alanjary Mohammad M, Aguinaldo Kristen, Korobeynikov Anton, Podell Sheila, Patin Nastassia, Lincecum Tommie, Jensen Paul R, Ziemert Nadine, Moore Bradley S
Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, USA.
German Centre for Infection Research (DZIF), Interfaculty Institute for Microbiology and Infection Medicine Tuebingen (IMIT), University of Tuebingen, Tuebingen, Germany.
Microbiology (Reading). 2016 Dec;162(12):2075-2086. doi: 10.1099/mic.0.000386. Epub 2016 Oct 27.
Traditional natural product discovery methods have nearly exhausted the accessible diversity of microbial chemicals, making new sources and techniques paramount in the search for new molecules. Marine actinomycete bacteria have recently come into the spotlight as fruitful producers of structurally diverse secondary metabolites, and remain relatively untapped. In this study, we sequenced 21 marine-derived actinomycete strains, rarely studied for their secondary metabolite potential and under-represented in current genomic databases. We found that genome size and phylogeny were good predictors of biosynthetic gene cluster diversity, with larger genomes rivalling the well-known marine producers in the Streptomyces and Salinispora genera. Genomes in the Micrococcineae suborder, however, had consistently the lowest number of biosynthetic gene clusters. By networking individual gene clusters into gene cluster families, we were able to computationally estimate the degree of novelty each genus contributed to the current sequence databases. Based on the similarity measures between all actinobacteria in the Joint Genome Institute's Atlas of Biosynthetic gene Clusters database, rare marine genera show a high degree of novelty and diversity, with Corynebacterium, Gordonia, Nocardiopsis, Saccharomonospora and Pseudonocardia genera representing the highest gene cluster diversity. This research validates that rare marine actinomycetes are important candidates for exploration, as they are relatively unstudied, and their relatives are historically rich in secondary metabolites.
传统的天然产物发现方法几乎已经穷尽了可获取的微生物化学物质的多样性,这使得新的来源和技术在寻找新分子的过程中至关重要。海洋放线菌最近成为焦点,因为它们能产生结构多样的次生代谢产物,且仍相对未被开发利用。在本研究中,我们对21株海洋来源的放线菌菌株进行了测序,这些菌株因其次生代谢产物潜力很少被研究,且在当前的基因组数据库中代表性不足。我们发现基因组大小和系统发育是生物合成基因簇多样性的良好预测指标,较大的基因组可与链霉菌属和盐孢菌属中著名的海洋生产者相媲美。然而,微球菌亚目的基因组中生物合成基因簇的数量始终是最少的。通过将单个基因簇连接成基因簇家族,我们能够通过计算估计每个属对当前序列数据库所贡献的新颖程度。基于联合基因组研究所生物合成基因簇图谱数据库中所有放线菌之间的相似性度量,罕见的海洋属显示出高度的新颖性和多样性,棒状杆菌属、戈登氏菌属、诺卡氏菌属、糖单孢菌属和假诺卡氏菌属具有最高的基因簇多样性。这项研究证实,罕见的海洋放线菌是重要的探索候选对象,因为它们相对未被研究,且其亲缘物种在历史上富含次生代谢产物。